Engineers Gate Manager’s Madrigal Pharmaceuticals MDGL Stock Holding History

Engineers Gate Manager’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$709K	Buy	+1,320	New	+$676K	0.01%	1283
2026 Q1	–	Sell	-8,708	Closed	-$5.07M	–	2411
2025 Q4	$5.07M	Buy	8,708 +5,774	+197%	+$2.95M	0.06%	338
2025 Q3	$1.35M	Sell	2,934 -1,489	-34%	-$556K	0.02%	998
2025 Q2	$1.34M	Buy	+4,423	New	+$1.32M	0.02%	962
2024 Q4	–	Sell	-1,501	Closed	-$319K	–	2444
2024 Q3	$319K	Buy	+1,501	New	+$384K	0.01%	1593
2023 Q4	–	Sell	-1,776	Closed	-$259K	–	2125
2023 Q3	$259K	Sell	1,776 -679	-28%	-$128K	0.01%	1390
2023 Q2	$567K	Sell	2,455 -3,001	-55%	-$813K	0.02%	981
2023 Q1	$1.32M	Buy	+5,456	New	+$1.49M	0.06%	469
2021 Q3	–	Sell	-6,002	Closed	-$585K	–	1834
2021 Q2	$585K	Buy	+6,002	New	+$710K	0.04%	746
2020 Q2	–	Sell	-4,602	Closed	-$307K	–	1871
2020 Q1	$307K	Sell	4,602 -1,509	-25%	-$126K	0.02%	1019
2019 Q4	$557K	Buy	+6,111	New	+$593K	0.02%	941

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Engineers Gate Manager's MDGL Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 1,320 shares worth $709K. The stake represents 0.01% of the portfolio and ranks #1283 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in MDGL as recently as Q4 2025.

Engineers Gate Manager first reported a position in MDGL in Q4 2019 and has held it in 11 quarters since. The position peaked at $5.07M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Engineers Gate Manager held 1,320 shares of Madrigal Pharmaceuticals worth $709K as of Q2 2026.
Madrigal Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
Madrigal Pharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1283 holding.
Engineers Gate Manager first reported a position in Madrigal Pharmaceuticals in Q4 2019 and has held it in 11 quarters since.
Engineers Gate Manager's Madrigal Pharmaceuticals position peaked at $5.07M in Q4 2025.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.